NEW DELHI: The government on Monday said it identified 26 potential cases of bleeding and blood clotting in India due...
covaxin
As the second COVID-19 wave continues to ravage the country, it is now clear that universal and swift vaccination is...
The Covaxin vaccine was launched in clinical trial mode as its third phase of trial was pending.New Delhi: Bharat Biotech...
NEW DELHI: Bharat Biotech on Sunday said its Covid-19 vaccine 'Covaxin' has been found to be effective against coronavirus strains...
The overall COVID-19 situation in the country is stabilizing and the government will work towards ensuring further stabilisation,...
Government on Saturday said that it would find out the basis of the decision taken by the UK...
Ten states account for 85 per cent of the total novel coronavirus cases in the country, the Union...
The Brihanmumbai Municipal Corporation has been meeting the second wave of the COVID-19 challenge on a war footing. Sonam Saigal...
Speaking to FE, Sunil Kumar Sharma, associate vice- president, BIBCOL, said the project is still in its initial stages and...
Plateauing in daily new Covid-19 cases and positivity rate has been recorded in the country over the past...
As states grapple with a shortage of coronavirus vaccines, the Centre Thursday said that over two billion doses...
Centre on Thursday said it accepted the recommendation of the COVID Working Group for extension of the gap...
The actor had returned to Chennai yesterday, after finishing a month-long schedule for his next film ‘Annaatthe’ in Hyderabad Superstar...
India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin...
The Drugs Controller General of India (DCGI) cleared Bharat Biotech's Covaxin trials on children from two to 18 years on...
The Covaxin trial involves two vaccine doses injected at day 0 and day 28.New Delhi: Clinical trials of Covaxin for...
Health minister Harsh Vardhan on Wednesday urged states to understand the limited availability of vaccines and not create...